Sachchida Nand Pandey

5PUBLICATIONS
6CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Process control and simulationPredictive and prognostic markersPharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 08, 2026
Association of Human Leucocyte Antigen with Tacrolimus Pharmacokinetics in Renal Transplant Patients.

Rashmi J Hemani, Amit S Joreja, Nitiraj B Shete

|Nov 27, 2025
Correction: Optimizing tacrolimus dosage in post‑renal transplantation using DoseOptimal framework: profiling CYP3A5 genetic variants for interpretability.

Chintal Upendra Raval, Ashwin Makwana, Samir Patel

|Mar 21, 2025
Optimizing tacrolimus dosage in post-renal transplantation using DoseOptimal framework: profiling CYP3A5 genetic variants for interpretability.

Chintal Upendra Raval, Ashwin Makwana, Samir Patel

|Nov 14, 2024
Synergistic Effect of Cytochrome P450 Family 3 Subfamily A Member 5 (CYP3A5) Genetic Variants in Tacrolimus Dose Determination in Indian Renal Transplant Patients.

Rashmi J Hemani, Priyal M Chauhan, Ratika Srivastava

|Dec 21, 2022
Suppression of TLR signaling by IRAK-1 and -4 dual inhibitor decreases TPF-resistance-induced pro-oncogenic effects in HNSCC.

Humayara Khan, Sachchida Nand Pandey, Abhishek Mishra

Pageof 1

Frequent Collaborators

3 joint publications

Rashmi J Hemani

2 joint publications

Ratika Srivastava

2 joint publications

Chintal Upendra Raval

2 joint publications

Ashwin Makwana